The fight against cancer is a continuous battle, and at its forefront are novel therapeutic agents that target cancer cells with unprecedented precision. Behind these advanced treatments lies a sophisticated network of chemical synthesis, where specific intermediate compounds are the unsung heroes. One such critical compound is 3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one (CAS 55314-16-4), an indispensable building block for some of the most impactful oncology drugs developed in recent decades.

This chemical intermediate is primarily recognized for its pivotal role in the synthesis of Imatinib and Nilotinib. Imatinib was a groundbreaking therapy, revolutionizing the treatment of chronic myeloid leukemia (CML) by inhibiting the BCR-ABL tyrosine kinase. Nilotinib, a subsequent development, offers an even more potent and targeted approach for CML treatment. The efficacy and widespread use of these drugs mean that the demand for high-quality 3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one is substantial and consistent. Pharmaceutical companies worldwide rely on its availability to maintain production and meet patient needs.

For R&D scientists and procurement specialists, securing a reliable supply of this intermediate is a strategic imperative. Key considerations when looking to buy include product purity (typically ≥98.0%), consistent physical properties (light yellow powder, melting point 86-88°C), and the reputation of the manufacturer or supplier. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted source for this compound, offering high-quality material essential for pharmaceutical synthesis. We understand the critical nature of these intermediates and are committed to delivering products that meet the most rigorous standards.

The commercial value of 3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one is directly tied to its indispensability in producing these life-saving cancer therapies. As an experienced supplier, we are dedicated to ensuring that pharmaceutical developers have access to this crucial component. We can provide detailed technical specifications and competitive pricing for bulk orders. If your organization is involved in oncology drug development or manufacturing, we encourage you to get a quote and explore how our reliable supply can support your critical work.